chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dull pain on left side of abdomen that started 3 days after first shot intensified over next three weeks/after the 2nd shot pain started to slowly decrease currently still experiencing it but it's more tolerable; Bloating occured any time I ate anything; Uncomfortable to sit or bend over; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 10Apr2021 at 12:00, (at the age of 36-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on an unknown date in 2021, both as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. On 14Apr2021 at 12:00, that started 3 days after first shot (as reported), the patient experienced dull pain on left side of abdomen, intensified over next three weeks, bloating occurred any time when the patient ate anything and it was uncomfortable to sit or bend over. After the second shot pain, started to slowly decrease. Currently, (at the time of reporting) patient was still experiencing it but was more tolerable. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dull pain on left side of abdomen, bloating occurred any time when the patient ate anything and uncomfortable to sit or bend over was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Nerve irritation throughout body; Numbness in feet; Vaginal flare up; Vaginal flare up; Viral shedding on lower back; Viral shedding on lower back; Lethargy; Also mild Covid reaction; This is a spontaneous report from a contactable consumer who is reported for herself that. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot number and Expiry date was not reported) via an unspecified route of administration in arm Left on 28Apr2021 (age at vaccination was 33-year-old) as dose1, single for COVID-19 immunization. Medical history included herpes simplex from an unknown date and unknown if ongoing Hsv2. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications received within 2 weeks of vaccination include vitamin b complex (B COMPLEX (B50), l-lysine acetate (L-LYSINE ACETATE), cholecalciferol (VITAMINS D3), calcium (CALCIUM), magnesium (MAGNESIUM), zinc (ZINC) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30May2021 patient experienced nerve irritation throughout body, numbness in feet, vaginal flare up, vaginal flare up, viral shedding on lower back, lethargy, on 30Apr2021 12:00 mild covid reaction (60 hours after the first shot). Due to the events patient visited Doctor or other healthcare professional office/clinic visit. Treatment received for the events was Home remedies and Zyrtec d. The outcome of the events was recovered with lasting effects on an unspecified date in 2021.  Information related to batch/Lot no. was requested.
Within a couple of minutes of receiving the vaccine, the patient began suffering an apparent seizure and lost consciousness. We called 911 and attended to the patient while waiting  for emergency personnel to arrive. The patient regained consciousness shortly after having apparent seizure and began to cry. She was breathing and had a pulse the entire time. She was transported to a local medical facility shortly after calling. We did not administer any Epi or other medications to treat the reaction.
fever, 102.5  aches, lethargic, stiffness, nausea, mid sternum pain and radiating to left chest sweats and chills
1250: presents with heart racing, HR: 144, BP: 142/90, Upper lip numbness, throat tightening, felt flush, complained of dryness to throat, drank a glass of water and tolerated Rapid response called; transferred to Ed
sore throat, cough, fatigue, headache, chills, shortness of breath, body aches, diarrhea, sinus congestion, nasal congestion, post nasal drainage, chest congestion, chest tightness, chest pain, patient has already tested positve two times with a home covid testing. starting 1/5/22
temperature excursion on PROQUAD reported lhat a dose was administered to a patient; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), 0.5 ml, lot # S017256, expiration date 01-DEC-2020 (dose and route of administration were not reported) for prophylaxis. The administered dose of vaccine experienced temperature excursion of - 13.7 degrees Celsius for 24 min. There was no previous temperature excursion reported. Digital data logger was involved.
Debilitating pain in abdomen.  Blood clot occluding intestine and kidney. ROMS performed with stent placed in artery and half of small intestine removed because it was dead.  3 more procedures were required within 6 days. During surgery found blood clot in kidney and later found blood clot in lung. While in hospital for 5 weeks had gout, respiratory failure and contracted Norovirus.
HYPOTENSION 1/12/2022 DM 2 W CKD STAGE 3A (GFR 45-59) W HTN  HYPOTENSION 1/12/2022 PAIN  HYPOTENSION 1/12/2022 DYSPHAGIA
First week of October 2022, I experienced extreme acid reflux and was having trouble swallowing food. I was able to see my nurse practitioner at the end of October who diagnosed me with GERD. I had an endoscope done in January that showed signs of esophageal and stomach cancer. I also had pathology and CT scan done that also confirmed malignancy. I've had my first two rounds of chemotherapy in February and am about to have my third round soon.
This spontaneous case reported by a consumer, describes the occurrence of sluggishness (felt really sluggish) and fatigue (felt tired) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 060E21A) for COVID-19 immunization. The patient's past medical history included COVID-19. On Sep 28, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced sluggishness (felt really sluggish) and fatigue (felt tired). At the time of the report, sluggishness (felt really sluggish) and fatigue (felt tired) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported. Reportedly, her next dose will be Oct 26, 2021.
Hives on on legs and arms; leading to bruising on legs from scratching. Treated with Benadryl and icing affected areas. Lasted about 10 days
This spontaneous report as received from a Certified Medical Assistant refers to unknown number of patients of unknown demographics. There was no information about the patients' concurrent conditions, concomitant therapies, drug reactions or allergies and medical history provided. On unknown dates, the patients were inadvertently administered ROTATEQ oral liquid (lot number M035452, expiration date 04-APR-2018, dose was not reported) that had been improperly stored. No adverse effects were reported. The vaccine experienced a temperature excursion of 47 Fahrenheit degrees (F) for 5 minutes, which was detected by a digital data logger. There was no previous temperature excursion. Lot number M035452 has been verified to be a valid lot number for ROTATEQ. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted. Sender's Comments: US-009507513-1701USA002059: US-009507513-1701USA002060: US-009507513-1701USA002061.
Patient received her first dose of the Pfizer vaccine today.  About five minutes after injection, patient developed shortness of breath and a burning chest pain. She was talking in complete sentences without any issues. She had no other symptoms.  Call placed to 911.  Her lungs were clear through out, her heart rate and rhythm was regular. See vitals below.  A 20g IV was placed to her L AC and Benadryl 25 mg IVP, Solumedrol 125 mg IVP and Famotidine 20 mg IVP was given by the RN. Her shortness of breath improved, the burning to her chest persisted.  EMS arrived at 0914 and she was transferred to the nearest hospital for further evaluation and treatment. Patient declined contacting any family members by the staff, she requested to call her husband herself.   03/17/21 0923 BP: (!) 162/70 Pulse: 110 Resp: 22 SpO2: 98%
Received fluvax on 10/31/01, child returned home from school on 11/1/01 stating left arm had been itching at school all day. Left deltoid was reddened, itching, and warm to touch. Advised pt to apply cool compress to site, and Benadryl as needed.
Information has been received from a physician concerning two male children 4 to 6 years of age who were vaccinated with the second dose of varicella virus vaccine live (Oka/Merck). Subsequently the patients experienced redness, pain and swelling at the injection site. Additional information has been requested. This is one of several reports received from the same source.
At around 11 pm, I started to feel nauseous. I had had a sore arm all day which I expected, but after trying to sleep it off I woke up around 2am shivering and sweating through my shirt at the same time, and had a 98.7 temperature (normally I am 97.2 so that's high for me). My arm started to have some swelling at the site, but I woke up this morning and the fever, chills, and nausea are still very much present about 24 hours after receiving the first dose.
5 or 5:30 on 5-15-12 arm turned red, HA, vomiting, chills, also swollen, redness surrounding injection site right posterior arm. ATARAX 25 mg TID prn.
Information has been received from a registered nurse concerning a patient who on 23-OCT-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (Lot # 658932/1343U). It was reported that the patient presented with cellulitis. A product quality complaint was not involved. Additional information has been requested. This is one of several reports received from the same source.
Within 24 hours fever> 100 (normal pt temp 97.8), hives, scratchy throat, deep cough. Longer lasting  effects, hair loss (more on left side), scratchy voice, hair loss.
Eyebrows were red, pt flush, no rash on face. No other signs or symptoms noted.
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-JUN-2017, the patient was inadvertently vaccinated with an expired dose of VAQTA injection, lot number M034893, expiration date: 26-MAY-2017 (strength, dose and route of administration were not reported) for prophylaxis. No adverse effects were reported and not product quality complaint (PQC) was involved. It was unknown if the patient sought medical attention.
Started feeling pain scale of 1 - 10 - 15, couldn't move arm w/o tremendous pain, trouble sleeping, then blotchy red spots on arm and shoulder. Pain was in shoulder and arm to elbow. Next day blotchy redness spots gone, and pain went from 9 to 7. Occurred approximately 6 hrs after shot received. Pt will go to MD 11/2/17.
Started running a fever on 9/20/12 of 101-102, even with alternating Tylenol and Ibuprofen per recommended schedule. On 9/21/12 at 8:30pm, it was 5.5 hours after prior dose of Ibuprofen- fever spiked to 106 degrees. Gave Ibuprofen and instituted cooling measures, and fever went down to 103 within 1 hour.
t103 x 3-4 days w/malaise, myalgia, h/a, nausea, diarrhea, edema @ site w/ecchymosis (rt deltoid);
dizzy; headache; Lousy; fever; generalized body aches; Did not feel well; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (generalized body aches), MALAISE (Did not feel well), DIZZINESS (dizzy) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced PYREXIA (fever), MYALGIA (generalized body aches) and MALAISE (Did not feel well). On 16-Apr-2021, the patient experienced DIZZINESS (dizzy), HEADACHE (headache) and ILLNESS (Lousy). At the time of the report, PYREXIA (fever), MYALGIA (generalized body aches) and MALAISE (Did not feel well) had resolved and DIZZINESS (dizzy), HEADACHE (headache) and ILLNESS (Lousy) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment was reported.
Severe fatigue, some nausea, headache, but the biggest concern is tenderness and swelling between the collar bone and neck in the left side.  I believe its one or more of my lymph nodes.
90 year old vaccinated female was admitted for PE with LLE DVT and signs of sepsis from UTI. Urine culture grew PCN resistant enterococcus. She has been anticoagulated. She tested (-) for Covid-19 infection on admission but was placed in Covid-19 unit due to recent exposure. She is DNR. Family requests palliative care services on discharge with hospital bed and O2.
Patient found dead two days after vaccination; A spontaneous report was received from a healthcare provider concerning 48-year-old, male patient who received Moderna's COVID-19 vaccine (mrna-1273) and died.  The patient's medical history includes bipolar disorder, colon polyps, hypertension, benign tremors & other Comorbidities. Concomitant product like iron sulfate, Fluticasone, Gabapentin, Lamotrigine, Methocarbamol, Propranolol hydrochloride was reported by the reporter .  On 11 mar 2021, approximately 2 days prior to the event, the patient received their first dose of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On 13 Mar 2021, the patient died. No other details were reported. Treatment information was unknown.   The patient died on 13 Mar 2021. The cause of death was not provided. Plans for an autopsy were unknown.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.; Reported Cause(s) of Death: Unknown cause of death
Information has been received from a registered nurse referring to a 62 year old patient of unknown gender. No relevant medical history or concurrent conditions was provided. On 08-APR-2015 the patient was vaccinated with an expired 0.65ml dose of ZOSTAVAX (lot # J014568, expiration date 18-FEB-2015) subcutaneously in the right arm. No adverse effects were reported. Additional information is not expected since the nurse is not allowed to be contacted.
pt recv vax 23OCT95 & on 12APR97 pt devel blistery rash consisting of over 100 spots, & exp a fever;
On Feb 10th, After dinner at about 7pm, , within about 15 min I started throwing up and also had diarrhea . My injection site became inflated to the size of a ping pong ball and VERY dark pink in color and extended out from the injection about 4 inches. I also had an enormously terrible headache and my sinuses were very sore and burning.  Approximately about every 15-20 minutes I was throwing up again until about 4am. This throw up was not chunky with food but more flemm  and jello like.  Finally around 4am I was able to get to sleep in a recliner chair until about 7am.   Currently it is 2:30pm on Feb 11th and my headache is just about gone, the soreness is gone from my body and I feel much better.   My major question is , Should I take the 2nd vaccination and will I have the same reactions to it.  What can I do to make myself feel better if I do get the 2nd shot. ?
DID NOT TAKE THE FOURTH DOSE; This spontaneous case (PVX2019-801) was received from a caregiver on 03-Apr-2019. It describes a 20-year-old adult female consumer who "did not take the fourth dose", while being on Vivotif for an unknown indication.   Case report: The consumer took 3 doses of Vivotif on 18-Mar-2019, 20-Mar-2019, and 22-Mar-2019 respectively. After that, her roommate had thrown out the fourth dose hence she missed to take it.  Action taken with Vivotif was not applicable.   The clinical outcome of the event "did not take the fourth dose" was unknown.  Company's Comment: The causality of the event "did not take the fourth dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not take the fourth dose" was considered as not applicable.
Skin issue (blisters) unidentified - rec'd multiple different types of treatment; generalized pain; fibroids, uterine swelling, lymph node swelling in breast, arm pits, neck, cartilage between ribs swollen, cardiac: htn, tachycardia, vtach, pvc, pac, svt, "spasms" of the arteries unknown, other newer cardiac issues currently undiagnosed, passing out, shortness of breath, GI issues though specialists put off tests until cardiac issues were stable, weight gain, insomnia.
I had flu like symptoms the first 48 hours with fogginess, tiredness, and achiness. The these symptoms seemed to get better after eating meals then got worse again off and on over the first 48 hours. When I woke up the day after the 2nd vaccine my left leg felt like it was going to give out walking on it almost like the feeling when you are pregnant and the muscles relax. This did not happen with the first dose. It lasted most of the day and part of the next eventually resolving with the right leg not showing that symptom at all. About 48 hours after the dose I experienced very painful lymph nodes. I'm breastfeeding and called my OB and described what felt like mastitis without red streaks or fever. My armpit, arm, and wrist ached. I have only experienced the wrist ache once with mastitis about 9 years ago. I'm currently taking sunflower lethicin and benadryl. Today is April 16th and I still have swollen lymph nodes and a sore arm and wrist.
After 1st dose, patient's boyfriend reported patient wasn't feeling well and was feeling nauseous. In the next minute or two, patient threw up on floor - mostly clear fluids. Patient was conscious and verbally responsive - she reported no unusual diet/intake of food prior, no excessive movement i.e. nothing out of ordinary prior to vaccine. Patient felt a bit nervous prior to vaccine & reports being nervous around needles in general, although no reaction to vaccine reported. Patient's vitals were measured - temp was normal, BP was normal & pulse was normal as well. Technician had ice pack around patient neck & head & water was provided as well. Patient reported feeling better after throwing up & patient was put under observation with technician for another couple of minutes & upon reporting that she felt okay and had a guardian with her, she was released & provided copy of VAER.
Large amount redness and soreness; warm to touch upper arm, swollen. Patient stated last time she had a Td she had a red area on arm. Diagnosis: Cellulitis.  Allergic reaction to Td.
Bruising under both of my hands; Headaches; severe arm pain; This is a spontaneous report from a contactable consumer (patient). A 21-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER 8734), via an unspecified route, administered in left arm on 18May2021 at 08:15 (at the age of 21-year-old), as first dose, single for covid-19 immunization at Pharmacy/drug store. The patient was not pregnant at the time of vaccination. The patient did not have any medical history and concomitant medication. The patient did not have any allergies at the time of reporting. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced bruising under both of her hands, headaches and severe arm pain on 18May2021 13:00. No treatment was received for the events. The outcome was reported as recovering for the reported events.
Headache, heaviness in head started within 12 hours of vaccine. Lasted about one day. No treatment. One day of work missed.
The patient is a 81 y.o. male patient of MD with history of past CVA, hypertension, and hyperlipidemia who presented to the Hospital with fatigue.   Acute hypoxic respiratory failure d/t COVID 19 infection Generalized Weakness Mainly symptoms of fatigue and generalized weakness at home Desaturated and initially placed on 5L NC, now off oxygen on RA Initial CBC with moderate leukocytosis (WBC 16.6), now 11.96 Unclear when symptoms started, but he states a few weeks. Vaccinated x1 (J&J) CTPA with no PE, some findings consistent with infectious bronchiolitis CRP elevated to 116 on arrival, now 47.6 Continue Decadron x10 days. Remdesivir not indicated PT/OT/CM consulted, appreciate assistance Discharged to SNF in stable condition, return precautions discussed Patient instructed to follow up with PCP    Abdominal Aortic Aneurysm Ascending Aortic Aneurysm Incidental findings on CTPA and CT abdomen/pelvis Ascending aneurysm stable with previous imaging Initially evaluated for transfer to hospital; however, per Vascular surgery this is not an acute issue AAA is only 3.5 x 3.6cm, does not meet cutoff for intervention. Stable 4.1 cm ascending AA.    Past CVA Hypertension Hyperlipidemia Cont losartan and metoprolol
This spontaneous report as received from a physician via an unspecified reporter through a company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 26-FEB-2015, the patient was vaccinated with VAQTA "25U/.5ML 10x1(ped), lot # J000985 with expiration date 20-AUG-2015 (route of administration unknown), which was stored at 32 F (0 Celsius Degrees) or 48 hours. The storage criteria and the type of excursion was refrigerator (R) and the vaccine status was reported as "in excursion". There were no concomitant therapies and adverse effects reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.